UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025771 |
|---|---|
| Receipt number | R000029107 |
| Scientific Title | Effects of Long-term Dapagliflozin Treatment on Hemorheology, Leukocyte Activation and Oxidative Stress |
| Date of disclosure of the study information | 2017/02/01 |
| Last modified on | 2021/01/26 14:22:55 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/20 18:08:22 | ||
| 2 | Update | 2017/01/30 18:13:52 | Anticipated trial start date |
|
| 3 | Update | 2017/02/01 09:28:15 | Anticipated trial start date |
|
| 4 | Update | 2017/02/01 09:28:52 | Date of disclosure of the study information |
|
| 5 | Update | 2017/04/06 16:14:15 | Organization Organization Organization Category of Funding Organization |
|
| 6 | Update | 2017/07/22 09:05:07 | Recruitment status |
|
| 7 | Update | 2018/02/01 12:15:21 | Recruitment status |
|
| 8 | Update | 2018/12/21 13:42:30 | Recruitment status |
|
| 9 | Update | 2019/01/24 16:48:07 | Last follow-up date |
|
| 10 | Update | 2019/02/15 15:24:49 | Last follow-up date |
|
| 11 | Update | 2019/07/24 15:24:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 12 | Update | 2019/07/24 16:24:03 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 13 | Update | 2019/07/24 16:28:09 | Date of IRB Last follow-up date |
|
| 14 | Update | 2021/01/26 14:22:55 | Email |
